An Update on the Pathogenesis and Treatment of Chronic Recurrent Multifocal Osteomyelitis in Children

Area of Science:

• Pediatric rheumatology and immunology
• Skeletal inflammatory diseases
• Autoinflammatory syndromes

Background:

• Chronic recurrent multifocal osteomyelitis (CRMO), also known as chronic non-bacterial osteomyelitis (CNO), is a rare pediatric inflammatory bone disorder.
• Characterized by bone pain, swelling, and osteomyelitis-like radiographic findings, often multifocal.
• Diagnosis is challenging, requiring exclusion of infection, malignancy, and other bone disorders.

Purpose of the Study:

• To provide an overview of recent advancements in understanding CRMO pathogenesis.
• To summarize current clinical approaches for diagnosing and managing CRMO.
• To highlight the need for established diagnostic and treatment guidelines.

Main Methods:

• Literature review of recent findings on CRMO pathogenesis.
• Analysis of current diagnostic criteria and differential diagnoses.
• Summary of established and emerging therapeutic strategies for CRMO.

Main Results:

• CRMO pathogenesis remains largely unknown, with ongoing research into underlying inflammatory mechanisms.
• Diagnosis relies on clinical presentation, imaging, and exclusion of other conditions; biopsy may be needed.
• First-line treatment includes NSAIDs, with corticosteroids, methotrexate, bisphosphonates, and TNF-α inhibitors used as alternatives.

Conclusions:

• CRMO is a complex autoinflammatory bone disease requiring a multidisciplinary approach.
• Further research into pathogenesis is crucial for developing targeted therapies.
• Standardized diagnostic and treatment guidelines are needed to optimize patient care.